Institutional investors purchased a net $1.1 million shares of SCLN during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 77.34% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEALTHINVEST PARTNERS AB Bought 236.3 Thousand shares of SciClone Pharmaceuticals ...